Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Georgios, Deftereos"'
Autor:
Valarie McMurtry, Jonathan Mahlow, Joshua F Coleman, Georgios Deftereos, Rakhi Jattani, Roy R L Bastien, Jacob Durtschi, Elke Jarboe, Lesley Lomo, Deepika Sirohi
Publikováno v:
American Journal of Clinical Pathology. 159:164-171
Objectives Fumarate hydratase (FH)–deficient tumors can occur due to germline or somatic mutations and have distinctive morphologic features. The aims of this study are to refine morphologic criteria and identify mutations in FH-deficient smooth mu
Publikováno v:
Diagnostic Cytopathology. 51:36-50
Thyroid nodules are commonly faced by clinicians as palpable nodules or incidentally identified on imaging. Nodules that are found to be suspicious by imaging can be biopsied by fine needle aspiration, which can yield material for molecular testing t
Autor:
Diane M. Wilcock, Kristina H. Moore, Leslie Rowe, Jonathan Mahlow, Jolanta Jedrzkiewicz, Allison S. Cleary, Lesley Lomo, Ana L. Ruano, Maarika Gering, Derek Bradshaw, Meghan Maughan, Phuong Tran, Jesse Burlingame, Richard Davis, Kajsa Affolter, Daniel J. Albertson, Parisa Adelhardt, Jong Take Kim, Joshua F Coleman, Georgios Deftereos, Evin H. Gulbahce, Deepika Sirohi
Publikováno v:
Archives of Pathology & Laboratory Medicine.
Context.— Quantitative imaging is a promising tool that is gaining wide use across several areas of pathology. Although there has been increasing adoption of morphologic and immunohistochemical analysis, the adoption for evaluation of fluorescence
Autor:
Diane M Wilcock, Larissa V. Furtado, Robert L. Schmidt, Deepika Sirohi, Georgios Deftereos, Anna P. Matynia
Publikováno v:
Applied Immunohistochemistry & Molecular Morphology. 30:19-26
ROS1 immunohistochemical (IHC) positivity requires follow-up with confirmatory testing such as fluorescence in situ hybridization (FISH). Identifying predictive characteristics of false positive ROS1 IHC cases could aid in optimizing testing algorith
Autor:
Diane M. Wilcock, Valarie McMurtry, Joshua F. Coleman, Jong Taek Kim, Parisa Khalili, Georgios Deftereos, Daniel Albertson, Evin H. Gulbahce, Ting Liu, Deepika Sirohi
Publikováno v:
International journal of surgical pathology. 30(7)
Background: Identification of MDM2 amplification by fluorescence in situ hybridization is an important diagnostic tool for evaluation of adipocytic neoplasms. Rarely, neoplasms can show increased copies of MDM2 and CEP12 probes (polysomy) without amp
Publikováno v:
Head Neck Pathol
Testing for high risk human papillomavirus (HR-HPV) status is standard of care in squamous cell carcinomas of the oropharynx as well as cervical lymph node squamous cell carcinomas of unknown primary origin. DNA or RNA in-situ hybridization (ISH) and
Autor:
Emily E. Waner, Malak Itani, Stephen C. Schmechel, Manjiri Dighe, Georgios Deftereos, Tracy Tylee
Publikováno v:
Diagnostic Cytopathology. 48:610-617
Background In the current version of The Bethesda System (TBS) for thyroid cytopathology, the atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS) category has an estimated risk of malignancy of 10% to 30%. Di
Publikováno v:
JCO Oncology Practice. 17:206-208
Publikováno v:
Applied immunohistochemistrymolecular morphology : AIMM. 30(1)
Background Upper tract urothelial carcinomas (UTUCs) are a rare and unique subset of urothelial carcinoma (UC). Patients with UTUC may qualify for treatment with immune checkpoint inhibitors if their tumor cells express programmed death ligand-1 (PD-
Background Upper tract urothelial carcinomas (UTUCs) are a rare and unique subset of urothelial carcinoma (UC). Immune checkpoint inhibitors are showing promise in the treatment of UC of the bladder and UTUC alike. While several large studies have lo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eeac02fd81d1a0cf220df8dcfec9f31b
https://doi.org/10.21203/rs.3.rs-22868/v1
https://doi.org/10.21203/rs.3.rs-22868/v1